FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35744011000001102: Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
109824501000001114 Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109824601000001113 Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Has specific active ingredient Naloxone hydrochloride dihydrate true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Is a Naloxone 1.8mg/0.1ml nasal spray unit dose true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Has active ingredient Naloxone true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxone false Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Is a Nyxoid true Inferred relationship Existential restriction modifier
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Has specific active ingredient Naloxone hydrochloride dihydrate false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) 2 unit dose 2 x 0.1ml unit doses Has AMP True Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start